Introduction: Glycosphingolipids in cell biology and disease.

Introduction: Glycosphingolipids in cell biology and disease.

Bibliographic Details
Main Authors:	Sillence, D, Platt, F
Format:	Journal article
Language:	English
Published:	2004

Similar Items

Glycosphingolipids in endocytic membrane transport.
by: Sillence, D, et al.
Published: (2004)

Glycosphingolipid storage leads to the enhanced degradation of the B cell receptor in Sandhoff disease mice.
by: te Vruchte, D, et al.
Published: (2010)

Accumulation of glycosphingolipids in Niemann-Pick C disease disrupts endosomal transport.
by: te Vruchte, D, et al.
Published: (2004)

Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis.
by: Jeyakumar, M, et al.
Published: (2002)

New therapeutics for the treatment of glycosphingolipid lysosomal storage diseases.
by: Butters, T, et al.
Published: (2003)

New developments in treating glycosphingolipid storage diseases.
by: Platt, F, et al.
Published: (2005)

ALTERED AUTOPHAGY AND APP METABOLISM IN GLYCOSPHINGOLIPID STORAGE DISEASES
by: Boland, B, et al.
Published: (2011)

Analysis of fluorescently labeled glycosphingolipid-derived oligosaccharides following ceramide glycanase digestion and anthranilic acid labeling.
by: Neville, D, et al.
Published: (2004)

Substrate reduction therapy for glycosphingolipid storage disorders.
by: Lachmann, R, et al.
Published: (2001)

Substrate deprivation: a new therapeutic approach for the glycosphingolipid lysosomal storage diseases.
by: Platt, F, et al.
Published: (2000)

Glycosphingolipid metabolism and its role in ageing and Parkinson’s disease
by: Wallom, K-L, et al.
Published: (2021)

Inhibition of glycosphingolipid biosynthesis: application to lysosomal storage disorders.
by: Butters, T, et al.
Published: (2000)

Diverse endogenous antigens for mouse NKT cells: self-antigens that are not glycosphingolipids.
by: Pei, B, et al.
Published: (2011)

Glycosphingolipid changes in plasma in Parkinson’s disease independent of glucosylceramide levels
by: te Vruchte, D, et al.
Published: (2022)

Lipidomics of Glycosphingolipids
by: Hany Farwanah, et al.
Published: (2012-02-01)

Cellular effects of deoxynojirimycin analogues: uptake, retention and inhibition of glycosphingolipid biosynthesis.
by: Mellor, H, et al.
Published: (2004)

Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases
by: Silk, J, et al.
Published: (2005)

Glycosphingolipids in human parasites
by: Richard D. Cummings
Published: (2023-09-01)

Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases.
by: Gadola, S, et al.
Published: (2006)

Modulation of THP-1 macrophage and cholesterol-loaded foam cell apolipoprotein E levels by glycosphingolipids.
by: Garner, B, et al.
Published: (2002)

The Role of Glycosphingolipids in Immune Cell Functions
by: Tao Zhang, et al.
Published: (2019-01-01)

Increased glycosphingolipid levels in serum and aortae of apolipoprotein E gene knockout mice.
by: Garner, B, et al.
Published: (2002)

Glycosphingolipid profiling of tissues from mouse models of human lysosomal storage disorders
by: Priestman, D, et al.
Published: (2008)

Structural diversity and biological significance of glycosphingolipids in pathogenic and opportunistic fungi
by: Luciana Lopes Guimaraes, et al.
Published: (2014-09-01)

Glycosphingolipid disorders of the brain.
by: Boomkamp, S, et al.
Published: (2008)

Effect of glycosphingolipids on osteoclastogenesis and osteolytic bone diseases.
by: Ersek, A, et al.
Published: (2012)

Effect of Glycosphingolipids on Osteoclastogenesis and Osteolytic Bone Diseases
by: Adel eErsek, et al.
Published: (2012-08-01)

Storage diseases: new insights into sphingolipid functions.
by: Sillence, D, et al.
Published: (2003)

Glycosphingolipid synthesis requires FAPP2 transfer of glucosylceramide.
by: D'Angelo, G, et al.
Published: (2007)

Glycosphingolipid levels and glucocerebrosidase activity are altered in normal aging of mouse brain
by: Hallett, PJ, et al.
Published: (2018)

The apo E gene knockout mouse as a model to study the potential atherogenic properties of glycosphingolipids
by: Garner, B, et al.
Published: (2003)

Differential sensitivity of mouse strains to an N-alkylated imino sugar: glycosphingolipid metabolism and acrosome formation.
by: van der Spoel, A, et al.
Published: (2008)

Glycosphingolipid dysregulation and lysosomal dysfunction in motor neuron disease
by: da Silva Santos, CS
Published: (2021)

Application of the Antibody-Inducing Activity of Glycosphingolipids to Human Diseases
by: Tetsuya Okuda
Published: (2021-04-01)

N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo.
by: Andersson, U, et al.
Published: (2000)

Glycolipids in cell biology and medicine - Introduction
by: Dwek, R, et al.
Published: (2003)

Glycosphingolipid–Protein Interaction in Signal Transduction
by: Domenico Russo, et al.
Published: (2016-10-01)

Increased glycosphingolipid levels in serum and aortae of apolipoprotein E gene knockout mice
by: Brett Garner, et al.
Published: (2002-02-01)

Quantitative isolation of total glycosphingolipids from animal cells
by: Terunobu Saito, et al.
Published: (1971-03-01)

Glycosphingolipids in Filamentous Fungi: Biological Roles and Potential Applications in Cosmetics and Health Foods
by: Chunmiao Jiang, et al.
Published: (2021-07-01)